These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 34658257)

  • 21. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
    Chen G; Dong Z; Wu D; Chen Y
    J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
    He J; Zhang W; Li F; Yu Y
    Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and validation of an immune-associated signature in lung adenocarcinoma.
    Wang Z; Chen X
    Int Immunopharmacol; 2020 Nov; 88():106867. PubMed ID: 32799112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
    Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
    Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment and validation of an eight-gene metabolic-related prognostic signature model for lung adenocarcinoma.
    Ma W; Liang J; Liu J; Tian D; Chen Z
    Aging (Albany NY); 2021 Feb; 13(6):8688-8705. PubMed ID: 33619235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
    Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G
    Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
    Niu W; Jiang L
    Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.
    Xu Z; Chen C
    Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anoikis-related gene signatures can aid prognosis of lung adenocarcinoma.
    Mo G; Long X; Hu Z; Tang Y; Zhou Z
    Adv Clin Exp Med; 2024 Jul; 33(7):751-761. PubMed ID: 37767763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.
    Pan Y; Jin X; Xu H; Hong J; Li F; Luo T; Zeng J
    Sci Rep; 2024 Jun; 14(1):13113. PubMed ID: 38849442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma.
    Liu Y; Wu Q; Fan X; Li W; Li X; Zhu H; Zhou Q; Yu J
    Sci Rep; 2021 Aug; 11(1):16794. PubMed ID: 34408216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering N
    Zhu J; Wang M; Hu D
    Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma.
    Tao Y; Li Y; Liang B
    Future Oncol; 2020 Aug; 16(24):1825-1837. PubMed ID: 32501723
    [No Abstract]   [Full Text] [Related]  

  • 40. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
    Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
    Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.